Vildagliptin 50 mg +Pioglitazone 15mg

Expand Your Product Line with the Cardio PCD Franchise of Vildagliptin +Pioglitazone Tablet.

Corazon Offers Sacubitril + Valsartan Tablet for PCD Franchise Owners.

Indian pharmaceutical business owners seeking to expand their product line with a Cardio PCD franchise, look no further than Corazon.

Vildagliptin and Pioglitazone are two different medications used to treat type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that helps to lower blood sugar levels by preventing the breakdown of incretin hormones that stimulate insulin release from the pancreas, while Pioglitazone is a thiazolidinedione that works by improving the sensitivity of the body's tissues to insulin.

Vildagliptin 50mg + Pioglitazone 15mg is a combination medication that contains both vildagliptin and pioglitazone in one tablet. It is used to help control blood sugar levels in people with type 2 diabetes who are not able to manage their diabetes with diet and exercise alone.

The recommended dosage of Vildagliptin 50mg + Pioglitazone 15mg is typically one tablet taken orally once a day with or without food. The dosage may be adjusted by a doctor based on the individual's response to the medication and other factors.

As with any medication, there can be potential side effects associated with Vildagliptin 50mg + Pioglitazone 15mg. These may include stomach upset, headache, dizziness, fluid retention, and low blood sugar (hypoglycemia). It is important to discuss any potential side effects and risks with a healthcare provider before starting treatment.